Physician profile
Mark D Widmann
NPI 1982674248
$24,545.33
in general payments reported to CMS, 2019-2025
22 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $27.49 · 2021: $58.52 · 2022: $20.81 · 2023: $1,596 · 2024: $6,044 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $4,055 · Education: $4,000 · Food and Beverage: $2,044 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,420.00 |
| Travel and Lodging | $4,055.44 |
| Education | $4,000.00 |
| Food and Beverage | $2,043.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $10,707.36 | 2023-2025 | Echelon; Endopath, Echelon Endopath, Echelon Flex |
| Medical Device Business Services, INC. | $6,033.56 | 2023-2025 | Echelon Flex, Monarch |
| Intuitive Surgical, INC. | $5,292.75 | 2024 | |
| On Target Laboratories, INC | $1,074.11 | 2024-2025 | Cytalux |
| Davol INC. | $301.44 | 2025 | Channel Drain |
| Csa Medical, INC | $280.77 | 2019 | |
| Stryker Corporation | $173.86 | 2024 | 1788 |
| Ethicon INC. | $131.88 | 2021-2023 | Monarch Platform |
| Galvanize Therapeutics, INC | $108.24 | 2024-2025 | Aliya System |
| Becton, Dickinson and Company | $69.55 | 2024 | Channel Drain |
| Merck Sharp & Dohme LLC | $62.65 | 2019-2025 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $58.33 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $56.95 | 2021-2023 | Ribfix Blu Advantage |
| Medtronic, INC. | $51.43 | 2023-2025 | Signia |
| E.R. Squibb & Sons, L.L.C. | $26.56 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $25.51 | 2024 | |
| Boston Scientific Corporation | $20.81 | 2022 | |
| Olympus America INC. | $16.04 | 2024 | Olympus |
| Foundation Medicine, INC. | $15.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.13 | 2019 | |
| Genentech USA, INC. | $13.14 | 2021 | |
| Kls-Martin L.P. | $10.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Widmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.